Genesis BPS — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

GenesisBPS is a private, commercial-stage company providing essential equipment and consumables for the blood processing and bioprocessing markets. Its product portfolio targets critical workflow steps in blood banking, cell therapy, and biopharma, emphasizing safety, reliability, and efficiency. The company's recent acquisition by GSI Group Holdings provides expanded resources and support for growth, positioning it as a focused supplier in a stable but specialized niche of the life sciences tools sector.

Drug Delivery

Technology Platform

Portfolio of specialized medical devices and consumables for sterile connection, thawing, sealing, mixing, and monitoring of blood, blood components, and laboratory fluids.

Opportunities

Growth is driven by the stable blood banking market and the rapidly expanding cell therapy and biopharma sectors, which require reliable processing tools.

Acquisition by GSI Group Holdings provides expanded resources and distribution channels for market penetration.

Risk Factors

Faces competition from larger established medical device companies.

Success depends on effective integration post-acquisition and navigating the regulated medical device environment.

Technological disruption in automated cell processing could threaten existing product lines.

Competitive Landscape

Competes in the niche blood processing and life science tools market against major players like Terumo BCT and Fresenius Kabi, as well as smaller specialized firms. Differentiation is based on product reliability, ease of use, and focused customer support for specific workflow pain points.

More companies in Diagnostics & Precision Medicine →More companies in United States →